TrialBMC cardiovascular disorders2018

Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort study.

Chaoyue Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.